Statement of changes in beneficial ownership of securities



>




X0306


4


2021-09-01


0



0001270073


INTERCEPT PHARMACEUTICALS, INC.


ICPT





0001595064


Richardson Linda M




C/O INTERCEPT PHARMACEUTICALS, INC.


10 HUDSON YARDS, FLOOR 37


NEW YORK


NY


10001






0


1


0


0


EVP & Chief Commercial Officer








The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Intercept Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

Intercept Pharmaceuticals Reports Second Quarter 2022 Financial Results And Provides Business Update - Aug. 3, 2022
Intercept Pharmaceuticals Just Filed Its Quarterly Report: 14.   Net Loss Per ... - Aug. 3, 2022
Intercept Pharmaceuticals's General Counsel just disposed of 771 shares - Aug. 3, 2022
On July - July 26, 2022
Intercept Pharmaceuticals's Chief Qual. Officer & SVP Ops. just disposed of 436 shares - July 13, 2022

Auto Refresh

Feedback